Cargando…

ECEIM consensus statement on equine metabolic syndrome

Equine metabolic syndrome (EMS) is a widely recognized collection of risk factors for endocrinopathic laminitis. The most important of these risk factors is insulin dysregulation (ID). Clinicians and horse owners must recognize the presence of these risk factors so that they can be targeted and cont...

Descripción completa

Detalles Bibliográficos
Autores principales: Durham, Andy E., Frank, Nicholas, McGowan, Cathy M., Menzies‐Gow, Nicola J., Roelfsema, Ellen, Vervuert, Ingrid, Feige, Karsten, Fey, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430910/
https://www.ncbi.nlm.nih.gov/pubmed/30724412
http://dx.doi.org/10.1111/jvim.15423
_version_ 1783405845211512832
author Durham, Andy E.
Frank, Nicholas
McGowan, Cathy M.
Menzies‐Gow, Nicola J.
Roelfsema, Ellen
Vervuert, Ingrid
Feige, Karsten
Fey, Kerstin
author_facet Durham, Andy E.
Frank, Nicholas
McGowan, Cathy M.
Menzies‐Gow, Nicola J.
Roelfsema, Ellen
Vervuert, Ingrid
Feige, Karsten
Fey, Kerstin
author_sort Durham, Andy E.
collection PubMed
description Equine metabolic syndrome (EMS) is a widely recognized collection of risk factors for endocrinopathic laminitis. The most important of these risk factors is insulin dysregulation (ID). Clinicians and horse owners must recognize the presence of these risk factors so that they can be targeted and controlled to reduce the risk of laminitis attacks. Diagnosis of EMS is based partly on the horse's history and clinical examination findings, and partly on laboratory testing. Several choices of test exist which examine different facets of ID and other related metabolic disturbances. EMS is controlled mainly by dietary strategies and exercise programs that aim to improve insulin regulation and decrease obesity where present. In some cases, pharmacologic aids might be useful. Management of an EMS case is a long‐term strategy requiring diligence and discipline by the horse's carer and support and guidance from their veterinarians.
format Online
Article
Text
id pubmed-6430910
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-64309102019-04-04 ECEIM consensus statement on equine metabolic syndrome Durham, Andy E. Frank, Nicholas McGowan, Cathy M. Menzies‐Gow, Nicola J. Roelfsema, Ellen Vervuert, Ingrid Feige, Karsten Fey, Kerstin J Vet Intern Med Consensus Statements Equine metabolic syndrome (EMS) is a widely recognized collection of risk factors for endocrinopathic laminitis. The most important of these risk factors is insulin dysregulation (ID). Clinicians and horse owners must recognize the presence of these risk factors so that they can be targeted and controlled to reduce the risk of laminitis attacks. Diagnosis of EMS is based partly on the horse's history and clinical examination findings, and partly on laboratory testing. Several choices of test exist which examine different facets of ID and other related metabolic disturbances. EMS is controlled mainly by dietary strategies and exercise programs that aim to improve insulin regulation and decrease obesity where present. In some cases, pharmacologic aids might be useful. Management of an EMS case is a long‐term strategy requiring diligence and discipline by the horse's carer and support and guidance from their veterinarians. John Wiley & Sons, Inc. 2019-02-06 2019 /pmc/articles/PMC6430910/ /pubmed/30724412 http://dx.doi.org/10.1111/jvim.15423 Text en © 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Consensus Statements
Durham, Andy E.
Frank, Nicholas
McGowan, Cathy M.
Menzies‐Gow, Nicola J.
Roelfsema, Ellen
Vervuert, Ingrid
Feige, Karsten
Fey, Kerstin
ECEIM consensus statement on equine metabolic syndrome
title ECEIM consensus statement on equine metabolic syndrome
title_full ECEIM consensus statement on equine metabolic syndrome
title_fullStr ECEIM consensus statement on equine metabolic syndrome
title_full_unstemmed ECEIM consensus statement on equine metabolic syndrome
title_short ECEIM consensus statement on equine metabolic syndrome
title_sort eceim consensus statement on equine metabolic syndrome
topic Consensus Statements
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430910/
https://www.ncbi.nlm.nih.gov/pubmed/30724412
http://dx.doi.org/10.1111/jvim.15423
work_keys_str_mv AT durhamandye eceimconsensusstatementonequinemetabolicsyndrome
AT franknicholas eceimconsensusstatementonequinemetabolicsyndrome
AT mcgowancathym eceimconsensusstatementonequinemetabolicsyndrome
AT menziesgownicolaj eceimconsensusstatementonequinemetabolicsyndrome
AT roelfsemaellen eceimconsensusstatementonequinemetabolicsyndrome
AT vervuertingrid eceimconsensusstatementonequinemetabolicsyndrome
AT feigekarsten eceimconsensusstatementonequinemetabolicsyndrome
AT feykerstin eceimconsensusstatementonequinemetabolicsyndrome